WCG Expands New Statistical Consulting Solutions to Address Industry Resource Challenges

WCG’s Statistical Consulting Solutions provide statistical support across all stages of clinical trial design and regulatory strategy from protocol reviews to final analyses.

AI Chatbots Emerge as a Promising Solution for Accessible Mental Healthcare

Mental health chatbots are surging in popularity due to the growing need for accessible and convenient care.

N4 Pharma’s novel delivery systems, Nuvec® and LipTide®, advance towards commercialisation

Creative Biogene Develops Comprehensive Microbial Platform with Streamlined Validation Method

IntegrateRNA Announces Comprehensive Services to Support Oligonucleotide Coupling Programs

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

Microbialtec Enhances Industrial Applications with Microbial Enzyme Production

Neobe Therapeutics raises over $2m for synthetic biology enabled tumour microenvironment remodelling

Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round.

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images

Kalderos Attracts Two Recognized Industry Leaders to Board of Directors

New Kalderos board members bring broad legal, regulatory, and corporate leadership experience across healthcare, biopharmaceutical, and pharmacy industries.

Optibrium Launches a Metabolism Prediction Software Platform Tailored to DMPK Scientists

Optibrium has launched Semeta™, a metabolism prediction platform tailored specifically for drug metabolism and pharmacokinetics (DMPK) scientists. Fundamental to improving a drug’s chance of clinical success, Semeta allows the accurate prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery, with superior precision to comparable software.

Avalon Saves Clients Millions, Sees Record Growth in 2023

Also, in 2023, Avalon launched Precision Genetic Testing Management (PGTM), the next evolution of its genetic test management solution.

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Celebrating International Women’s Day and tackling inequality at Discovery Park

Discovery Park, Kent’s thriving life science community, is marking International Women’s Day by supporting women in business and tackling gender bias in healthcare.

Automation and Robotics Reshaping the Future of Care

The healthcare industry is embracing automation and robotics, offering exciting changes. Automation empowers healthcare providers by streamlining tasks and allowing for personalized medicine.

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS

Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.